Navigation Links
PHSI, INC. Develops Revolutionary Vision-Hearing Program
Date:10/28/2009

Ophthalmology Receives Stimulus from Experienced Hearing Healthcare Provider

Bonita Springs, FL (PRWEB) October 28, 2009 -- PHSI (Physician Hearing Services Inc.), the unquestioned leader in Vision-Hearing programs, has made unprecedented advances in providing ophthalmologists with the tools needed to care for an ever-growing demographic of patients. The company has just launched an intuitive new website aimed at providing even more information and heightening the user experience.
Deemed "The Original Hearing and Vision Company", PHSI already works with the most progressive ophthalmic practices in the nation, both large and small, to combine hearing loss diagnosis and treatment with premier vision services. PHSI provides comprehensive guidance in all facets of their hearing and vision program which not only increases the patient's quality of life, but is also immensely profitable for the ophthalmology practice itself. Estimates range 30 to 55 million people in the U.S. have undiagnosed, clinically significant hearing loss, and PHSI has developed a proven method for vision professionals to add essential hearing services to their offerings. 80% of patients with hearing loss never receive treatment, therefore providing this service gives patients assistance they both need and want.

"A hearing program is a natural and simple extension of your ophthalmic practice and requires little effort on your part," states John Olive, President of PHSI, LLC. "It will provide a much needed service to your patients and sorely needed profits to your bottom line. Vision and hearing together is a natural fit"

PHSI is and will remain at the forefront of this exciting new business model. Physician's Hearing Service, Inc. provides you with a step-by-step, 'out-of-the-box' solution to building and operating a successful hearing program. From day one, you will be guided through the process of equipping, setting up, staffing, stocking, opening, and operating your hearing program, all while retaining complete ownership. With little effort on your part, you can increase your bottom line without changing locations or searching for a new client base. Utilizing your current patients, PHSI will provide action plans, forms, script notes, marketing materials, strategies, and ongoing consultation towards your successful venture into adding a hearing program to your clinic.

PHSI management will welcome your questions and interests at the AAO Show in San Francisco, Booth # 5023.

About Us: Physician's Hearing Service, Inc was founded by Reg Garratt and John Olive, two Senior partners that have identified the need for more hearing health professionals. Garratt and Olive joined forces in the year 2000 when they served together as Chairman and Executive Director of the Better Hearing Institute in Washington, DC. Their extensive backgrounds in healthcare marketing and planning, as well as hearing aids and hospital management, have fostered their continuing prosperous relationship into the hearing healthcare industry.

# # #

Read the full story at http://www.prweb.com/releases/2009/10/prweb3122414.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Safety Management Services, Inc. Develops New Regional Preparation Course And Exam For CHEP Certification
2. MyEMRchoice.com develops EMR Power Rankings for Selection of Electronic Medical Records
3. Panel Intelligence Develops Extensive Access to Patient Populations in Oncology
4. Tissue Banks International Develops Expanded Ocular Services Division
5. Carnegie Mellon develops innovative method to detect genetic causes of complex diseases
6. Mass. General team develops potentially safer general anesthetic
7. Team Develops Anti-Infection Technology
8. NC State develops new test method to measure stored heat in firefighter suits
9. Solos Endoscopy, Inc. Develops Specialized Endocoupler for the MammoView(TM)
10. Siemens Further Develops its syngo Dynamics Solution
11. SaltCheck Develops First Simplified Test for Monitoring Salt Intake in People With Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: